Hormones, Prostaglandins, Thromboxanes And Leukotrienes Market

The article discusses the global market trends for hormones, prostaglandins, thromboxanes, and leukotrienes, indicating an upward consumption trend with forecasted growth in volume and value terms. Ireland leads in both consumption and production levels, with China as the key exporter. Key importers include Italy, Canada, and the United States. Growth rates, trends, and fluctuations over a decade are thoroughly analyzed, showcasing how different countries have evolved in terms of market size, consumption per capita, production volumes, import/export patterns, and average prices.

Market Forecast

Driven by increasing demand for hormones, prostaglandins, thromboxanes and leukotrienes worldwide, the market is expected to continue an upward consumption trend over the next eight-year period. Market performance is forecast to decelerate, expanding with an anticipated CAGR of +1.9% for the period from 2022 to 2030, which is projected to bring the market volume to 18K tons by the end of 2030.

In value terms, the market is forecast to increase with an anticipated CAGR of +2.9% for the period from 2022 to 2030, which is projected to bring the market value to $120.9B (in nominal prices) by the end of 2030.

Consumption

World Consumption of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

In 2022, the amount of hormones, prostaglandins, thromboxanes and leukotrienes consumed worldwide surged to 15K tons, with an increase of 46% against 2021. Overall, consumption showed resilient growth. Global consumption peaked in 2022 and is likely to see gradual growth in the immediate term.

The revenue of the market for hormones, prostaglandins, thromboxanes and leukotrienes worldwide surged to $95.8B in 2022, increasing by 47% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Over the period under review, consumption posted a resilient expansion. As a result, consumption attained the peak level and is likely to continue growth in the immediate term.

Consumption By Country

Ireland (4.2K tons) constituted the country with the largest volume of hormones, prostaglandins, thromboxanes and leukotrienes consumption, accounting for 28% of total volume. Moreover, hormones, prostaglandins, thromboxanes and leukotrienes consumption in Ireland exceeded the figures recorded by the second-largest consumer, Italy (1.9K tons), twofold. China (1.7K tons) ranked third in terms of total consumption with an 11% share.

From 2012 to 2022, the average annual growth rate of volume in Ireland stood at +20.9%. In the other countries, the average annual rates were as follows: Italy (+15.1% per year) and China (+2.7% per year).

In value terms, the largest hormones, prostaglandins, thromboxanes and leukotrienes markets worldwide were Ireland ($36.1B), Japan ($22.1B) and Italy ($9.2B), with a combined 70% share of the global market.

Ireland, with a CAGR of +19.3%, recorded the highest growth rate of market size among the main consuming countries over the period under review, while market for the other global leaders experienced more modest paces of growth.

In 2022, the highest levels of hormones, prostaglandins, thromboxanes and leukotrienes per capita consumption was registered in Ireland (837 kg per 1000 persons), followed by Italy (33 kg per 1000 persons), Canada (28 kg per 1000 persons) and Malaysia (8.3 kg per 1000 persons), while the world average per capita consumption of hormones, prostaglandins, thromboxanes and leukotrienes was estimated at 1.9 kg per 1000 persons.

From 2012 to 2022, the average annual growth rate of the hormones, prostaglandins, thromboxanes and leukotrienes per capita consumption in Ireland totaled +19.8%. In the other countries, the average annual rates were as follows: Italy (+15.2% per year) and Canada (+9.8% per year).

Production

World Production of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

In 2022, approx. 13K tons of hormones, prostaglandins, thromboxanes and leukotrienes were produced worldwide; with an increase of 13% on 2021. In general, the total production indicated resilient growth from 2012 to 2022: its volume increased at an average annual rate of +7.0% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by -7.5% against 2020 indices. The pace of growth was the most pronounced in 2019 with an increase of 29%. Over the period under review, global production attained the peak volume at 14K tons in 2020; however, from 2021 to 2022, production stood at a somewhat lower figure.

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes production totaled $80.1B in 2022 estimated in export price. Overall, production showed a buoyant expansion. The growth pace was the most rapid in 2019 with an increase of 34%. Global production peaked at $89B in 2020; however, from 2021 to 2022, production failed to regain momentum.

Production By Country

The countries with the highest volumes of production in 2022 were Ireland (4.9K tons), China (3.6K tons) and Brazil (508 tons), with a combined 68% share of global production.

From 2012 to 2022, the most notable rate of growth in terms of production, amongst the leading producing countries, was attained by Ireland (with a CAGR of +22.8%), while production for the other global leaders experienced more modest paces of growth.

Imports

World Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

In 2022, overseas purchases of hormones, prostaglandins, thromboxanes and leukotrienes increased by 30% to 7K tons, rising for the third consecutive year after two years of decline. In general, imports enjoyed resilient growth. The most prominent rate of growth was recorded in 2017 when imports increased by 104%. As a result, imports reached the peak of 8.1K tons. From 2018 to 2022, the growth of global imports remained at a lower figure.

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes imports soared to $25.7B in 2022. Overall, total imports indicated a prominent increase from 2012 to 2022: its value increased at an average annual rate of +5.0% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by +84.4% against 2016 indices. The growth pace was the most rapid in 2019 when imports increased by 20% against the previous year. Global imports peaked in 2022 and are likely to see steady growth in the immediate term.

Imports By Country

In 2022, Italy (1.8K tons), distantly followed by Canada (1,083 tons), India (741 tons), the United States (584 tons) and Pakistan (322 tons) represented the largest importers of hormones, prostaglandins, thromboxanes and leukotrienes, together comprising 64% of total imports. Belgium (299 tons), Spain (275 tons), France (263 tons), Brazil (135 tons), Germany (127 tons) and the Netherlands (111 tons) held a little share of total imports.

From 2012 to 2022, the biggest increases were recorded for Italy (with a CAGR of +29.3%), while purchases for the other global leaders experienced more modest paces of growth.

In value terms, the largest hormones, prostaglandins, thromboxanes and leukotrienes importing markets worldwide were the United States ($7.2B), Belgium ($3.8B) and Italy ($3B), together comprising 55% of global imports.

In terms of the main importing countries, the United States, with a CAGR of +18.4%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other global leaders experienced more modest paces of growth.

Import Prices By Country

In 2022, the average import price for hormones, prostaglandins, thromboxanes and leukotrienes amounted to $3,665 per kg, waning by -8% against the previous year. Over the period under review, the import price saw a relatively flat trend pattern. The pace of growth was the most pronounced in 2018 an increase of 56% against the previous year. Global import price peaked at $4,327 per kg in 2014; however, from 2015 to 2022, import prices failed to regain momentum.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Germany ($13,593 per kg), while Pakistan ($180 per kg) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the United States (+19.4%), while the other global leaders experienced more modest paces of growth.

Exports

World Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

In 2022, shipments abroad of hormones, prostaglandins, thromboxanes and leukotrienes decreased by -24.5% to 5.1K tons, falling for the second year in a row after three years of growth. Over the period under review, exports, however, posted perceptible growth. The pace of growth appeared the most rapid in 2019 when exports increased by 48% against the previous year. Over the period under review, the global exports attained the peak figure at 9K tons in 2020; however, from 2021 to 2022, the exports stood at a somewhat lower figure.

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes exports expanded modestly to $22.4B in 2022. In general, total exports indicated a tangible increase from 2012 to 2022: its value increased at an average annual rate of +2.4% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports increased by +62.1% against 2016 indices. The most prominent rate of growth was recorded in 2019 with an increase of 19% against the previous year. Over the period under review, the global exports attained the maximum in 2022 and are expected to retain growth in the near future.

Exports By Country

In 2022, China (1.9K tons) was the key exporter of hormones, prostaglandins, thromboxanes and leukotrienes, mixing up 38% of total exports. Ireland (762 tons) took a 15% share (based on physical terms) of total exports, which put it in second place, followed by the United States (7.2%) and Spain (6%). The following exporters - Denmark (220 tons), India (207 tons), Belgium (186 tons), France (185 tons), Germany (180 tons), Italy (177 tons) and Rwanda (135 tons) - together made up 25% of total exports.

Exports from China increased at an average annual rate of +7.9% from 2012 to 2022. At the same time, Rwanda (+2,141.7%), Denmark (+20.2%), Ireland (+17.3%), Belgium (+5.0%) and Italy (+2.2%) displayed positive paces of growth. Moreover, Rwanda emerged as the fastest-growing exporter exported in the world, with a CAGR of +2,141.7% from 2012-2022. Spain and the United States experienced a relatively flat trend pattern. By contrast, France (-3.8%), India (-4.3%) and Germany (-4.7%) illustrated a downward trend over the same period. China (+14 p.p.), Ireland (+11 p.p.), Denmark (+3.4 p.p.) and Rwanda (+2.6 p.p.) significantly strengthened its position in terms of the global exports, while Spain, the United States, France, Germany and India saw its share reduced by -2%, -2.9%, -3.6%, -4.3% and -4.5% from 2012 to 2022, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Ireland ($7.5B) remains the largest hormones, prostaglandins, thromboxanes and leukotrienes supplier worldwide, comprising 34% of global exports. The second position in the ranking was held by the United States ($2.4B), with an 11% share of global exports. It was followed by Denmark, with an 8.5% share.

In Ireland, hormones, prostaglandins, thromboxanes and leukotrienes exports expanded at an average annual rate of +16.7% over the period from 2012-2022. The remaining exporting countries recorded the following average annual rates of exports growth: the United States (-2.0% per year) and Denmark (+13.1% per year).

Export Prices By Country

The average export price for hormones, prostaglandins, thromboxanes and leukotrienes stood at $4,386 per kg in 2022, rising by 36% against the previous year. Overall, the export price, however, showed a relatively flat trend pattern. Over the period under review, the average export prices attained the maximum at $4,704 per kg in 2012; however, from 2013 to 2022, the export prices failed to regain momentum.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Ireland ($9,873 per kg), while Rwanda ($13 per kg) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Rwanda (+50.7%), while the other global leaders experienced more modest paces of growth.

Source: IndexBox Market Intelligence Platform